Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
P/S ratio for Organogenesis (ORGO)
P/S ratio as of April 2024 (TTM): 0.7160
According to Organogenesis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.715965. At the end of 2023 the company had a P/S ratio of 1.24.
P/S ratio history for Organogenesis from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.24 | 58.76% |
| 2022 | 0.7810 | -69.25% |
| 2021 | 2.54 | -10.68% |
| 2020 | 2.84 | 47.1% |
| 2019 | 1.93 | -33.07% |
| 2018 | 2.89 | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.02 | 42.05% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 12,819.43% | 🇺🇸 USA |